For citations:
Semenov N.N., Fedyanin M.Yu., Zhukova L.G., Khatkov I.E., Stroyakovskii D.L., Pokataev I.A. The results of the use of immune checkpoint inhibitors (ICI) pembrolizumab and nivolumab in the first line treatment of patients with metastatic gastric cancer. The experience of the oncological service of Moscow. Malignant tumours. 2025;15(1):27–35. (In Russ.) https://doi.org/10.18027/2224-5057-2025-039